Navigation Links
2010 FEBS/EMBO Women in Science award honors Ingrid Grummt

Heidelberg, Germany, 10 February 2010 The European Molecular Biology Organization (EMBO) and the Federation of European Biochemical Societies (FEBS) announced Ingrid Grummt from the German Cancer Research Center in Heidelberg, Germany, as the winner of the 2010 FEBS/EMBO Women in Science Award. Ingrid Grummt has made important contributions to the field of transcriptional regulation in cells throughout her career.

The FEBS/EMBO Women in Science Award, now in its third year, recognizes and rewards the exceptional achievements of a female researcher in molecular biology over the previous five years. Winners of the award are role models who inspire future generations of women in science. "Ingrid Grummt is an outstanding scientist who has made seminal contributions in the field of regulation of gene expression, including the very recent discoveries that link ageing and some inherited diseases with the silencing of genes required for cell growth," said selection committee member Claudio Sunkel, Director of the Institute of Molecular and Cellular Biology in Porto, Portugal.

The 2010 winner is distinguished not only for scientific contributions but also for her commitment to the development of European science through her active service on various advisory boards, panels and scientific committees.

"It is important to me to inspire young women to face personal and professional challenges, to help them mobilize their strengths when in doubt and motivate and encourage them to keep their eyes on their goals. I think that integrating career and personal goals makes people happier and more productive in the long run," said the award winner.

Prior to joining the German Cancer Research Center, Ingrid was a post-doctoral fellow at the German Academy of Sciences in Berlin and the Max Planck Institute of Biochemistry in Munich, and led a research group at the University in Wrzburg, Germany. She was honoured with prestigious awards such as the Science Prize of the Fritz-Winter-Foundation and the Gottfried Wilhelm Leibniz-Prize for German scientists.

The 2010 FEBS/EMBO Women in Science Award of 10,000 euro will be presented to Ingrid Grummt on 30 June at the 35th FEBS Congress in Gothenburg, Sweden, where she will present a special lecture.


Contact: Suzanne Beveridge
European Molecular Biology Organization

Related biology news :

1. Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women
2. Few women take tamoxifen to prevent breast cancer
3. New research shows genes of pregnant women and their fetuses can increase the risk of preterm labor
4. Finally, an excuse for pregnant women to eat bacon and eggs
5. Lower income women report more insurance-based discrimination during pregnancy, delivery
6. Many pregnant women avoid HIV screening in Africa
7. Toward explaining why hepatitis B hits men harder than women
8. Saliva proteins change as women age
9. 5 exercises can reduce neck, shoulder pain of women office workers
10. Women at risk from vitamin A deficiency
11. Attention-deficit/hyperactivity problems associated with low folate levels in pregnant women
Post Your Comments:
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: